281 related articles for article (PubMed ID: 32632539)
1. The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods.
Krebs A; van Vugt-Lussenburg BMA; Waldmann T; Albrecht W; Boei J; Ter Braak B; Brajnik M; Braunbeck T; Brecklinghaus T; Busquet F; Dinnyes A; Dokler J; Dolde X; Exner TE; Fisher C; Fluri D; Forsby A; Hengstler JG; Holzer AK; Janstova Z; Jennings P; Kisitu J; Kobolak J; Kumar M; Limonciel A; Lundqvist J; Mihalik B; Moritz W; Pallocca G; Ulloa APC; Pastor M; Rovida C; Sarkans U; Schimming JP; Schmidt BZ; Stöber R; Strassfeld T; van de Water B; Wilmes A; van der Burg B; Verfaillie CM; von Hellfeld R; Vrieling H; Vrijenhoek NG; Leist M
Arch Toxicol; 2020 Jul; 94(7):2435-2461. PubMed ID: 32632539
[TBL] [Abstract][Full Text] [Related]
2. The need for strategic development of safety sciences.
Busquet F; Hartung T
ALTEX; 2017; 34(1):3-21. PubMed ID: 28105478
[TBL] [Abstract][Full Text] [Related]
3. Internationalization of read-across as a validated new approach method (NAM) for regulatory toxicology.
Rovida C; Barton-Maclaren T; Benfenati E; Caloni F; Chandrasekera PC; Chesné C; Cronin MTD; De Knecht J; Dietrich DR; Escher SE; Fitzpatrick S; Flannery B; Herzler M; Hougaard Bennekou S; Hubesch B; Kamp H; Kisitu J; Kleinstreuer N; Kovarich S; Leist M; Maertens A; Nugent K; Pallocca G; Pastor M; Patlewicz G; Pavan M; Presgrave O; Smirnova L; Schwarz M; Yamada T; Hartung T
ALTEX; 2020; 37(4):579-606. PubMed ID: 32369604
[TBL] [Abstract][Full Text] [Related]
4. Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk.
Daneshian M; Kamp H; Hengstler J; Leist M; van de Water B
Arch Toxicol; 2016 May; 90(5):1021-4. PubMed ID: 27017488
[TBL] [Abstract][Full Text] [Related]
5. Deepening uncertainty on how the EU may regulate supposable endocrine disruptors.
Gori GB; Dekant W
Regul Toxicol Pharmacol; 2016 Nov; 81():8-9. PubMed ID: 27350054
[No Abstract] [Full Text] [Related]
6. Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience.
Moné MJ; Pallocca G; Escher SE; Exner T; Herzler M; Bennekou SH; Kamp H; Kroese ED; Leist M; Steger-Hartmann T; van de Water B
Arch Toxicol; 2020 Oct; 94(10):3581-3592. PubMed ID: 32886186
[TBL] [Abstract][Full Text] [Related]
7. Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project.
Escher SE; Kamp H; Bennekou SH; Bitsch A; Fisher C; Graepel R; Hengstler JG; Herzler M; Knight D; Leist M; Norinder U; Ouédraogo G; Pastor M; Stuard S; White A; Zdrazil B; van de Water B; Kroese D
Arch Toxicol; 2019 Dec; 93(12):3643-3667. PubMed ID: 31781791
[TBL] [Abstract][Full Text] [Related]
8. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
Bal-Price A; Hogberg HT; Crofton KM; Daneshian M; FitzGerald RE; Fritsche E; Heinonen T; Hougaard Bennekou S; Klima S; Piersma AH; Sachana M; Shafer TJ; Terron A; Monnet-Tschudi F; Viviani B; Waldmann T; Westerink RHS; Wilks MF; Witters H; Zurich MG; Leist M
ALTEX; 2018; 35(3):306-352. PubMed ID: 29485663
[TBL] [Abstract][Full Text] [Related]
9. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
10. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
Spielmann H; Liebsch M
Toxicol In Vitro; 2001; 15(4-5):585-90. PubMed ID: 11566595
[TBL] [Abstract][Full Text] [Related]
12. Priority setting in the REACH system.
Hansson SO; Rudén C
Toxicol Sci; 2006 Apr; 90(2):304-8. PubMed ID: 16340010
[TBL] [Abstract][Full Text] [Related]
13. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
14. Alternative test methods in inhalation toxicology: challenges and opportunities.
Costa DL
Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
[TBL] [Abstract][Full Text] [Related]
15. Workshop on the validation and regulatory acceptance of innovative 3R approaches in regulatory toxicology - Evolution versus revolution.
Burgdorf T; Piersma AH; Landsiedel R; Clewell R; Kleinstreuer N; Oelgeschläger M; Desprez B; Kienhuis A; Bos P; de Vries R; de Wit L; Seidle T; Scheel J; Schönfelder G; van Benthem J; Vinggaard AM; Eskes C; Ezendam J
Toxicol In Vitro; 2019 Sep; 59():1-11. PubMed ID: 30946968
[TBL] [Abstract][Full Text] [Related]
16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
17. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
18. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
Sachana M; Bal-Price A; Crofton KM; Bennekou SH; Shafer TJ; Behl M; Terron A
Toxicol Sci; 2019 Jan; 167(1):45-57. PubMed ID: 30476307
[TBL] [Abstract][Full Text] [Related]
19. Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs.
Bal-Price AK; Suñol C; Weiss DG; van Vliet E; Westerink RH; Costa LG
Neurotoxicology; 2008 May; 29(3):520-31. PubMed ID: 18417220
[TBL] [Abstract][Full Text] [Related]
20. Integrated testing strategy (ITS) for bioaccumulation assessment under REACH.
Lombardo A; Roncaglioni A; Benfentati E; Nendza M; Segner H; Fernández A; Kühne R; Franco A; Pauné E; Schüürmann G
Environ Int; 2014 Aug; 69():40-50. PubMed ID: 24806447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
